SCHEMBL1697117

SCHEMBL1697117

CCCc1ccc2c(Nc3cccc(OCC(=O)OC(C)C)c3)cccc2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIRT2 Q8IXJ6 8/20 0.41
PSEN1 P49768 1/20 0.41
PSEN2 P49810 1/20 0.41
APH1B Q8WW43 1/20 0.41
NCSTN Q92542 1/20 0.41
APH1A Q96BI3 1/20 0.41
PSENEN Q9NZ42 1/20 0.41
PSMB5 P28074 1/20 0.41
CDC25B P30305 1/20 0.40
RXFP1 Q9HBX9 1/20 0.39
CTSV O60911 1/20 0.39
CTSL P07711 1/20 0.39
PPARG P37231 1/20 0.39
PPARA Q07869 1/20 0.39
MAPT P10636 1/20 0.38
NR1H4 Q96RI1 1/20 0.38
ROCK2 O75116 1/20 0.38
ROCK1 Q13464 1/20 0.38
ALDH1A1 P00352 1/20 0.38
CYP1A2 P05177 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL370943 0.87 PPARA (0.49) SIRT2PSEN1PSEN2APH1BNCSTN
SCHEMBL15416998 0.86 KMT2A (0.45) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL371036 0.83 PSEN1 (0.44) SIRT2PSEN1PSEN2APH1BNCSTN
SCHEMBL1697010 0.81 PPARA (0.56) SIRT2PSEN1PSEN2APH1BNCSTN
SCHEMBL12503324 0.80 PPARA (0.60) SIRT2PSEN1PSEN2APH1BNCSTN
SCHEMBL344104 0.80 THRB (0.44) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL344686 0.80 PPARA (0.47) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL343323 0.79 PPARA (0.48) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL344807 0.79 PPARA (0.48) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL15417050 0.78 KDR (0.51) ROCK2ROCK1ALDH1A1CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012003145-A2 THERAPEUTIC AGENTS FOR OCULAR HYPERTENSION ALLERGAN, INC. (US) 2012-01-05 WO disclosed